Utility of gonadotropin-releasing hormone agonists for fertility preservation: Lack of biologic basis and the need to prioritize proven methods

dc.contributor.author	Turan, V.
dc.contributor.author	Bedoschi, G.
dc.contributor.author	Rodriguez-Wallberg, K.
dc.contributor.author	Sonmezer, M.
dc.contributor.author	Silva, Pacheco, F.
dc.contributor.author	Oktem, O.
dc.contributor.author	Taylor, H.
dc.contributor.author	Oktay, K.
dc.date.accessioned	2021-12-21T08:41:00Z
dc.date.available	2021-12-21T08:41:00Z
dc.date.issued	2019
dc.identifier.issn	0732183X
dc.identifier.uri	https://doi.org/10.1200/JCO.18.00420
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1286
dc.description.abstract	[No abstract available]
dc.description.sponsorship	K.O. is supported by NIH RO1 HD053112. K.O. is the co-chair of the ASCO Clinical Guidelines Committee for Fertility Preservation.
dc.language.iso	English
dc.publisher	American Society of Clinical Oncology
dc.title	Utility of gonadotropin-releasing hormone agonists for fertility preservation: Lack of biologic basis and the need to prioritize proven methods
dc.type	Letter
dc.relation.journal	Journal of Clinical Oncology
dc.identifier.issue	1
dc.identifier.startpage	84
dc.identifier.endpage	86
dc.identifier.volume	37
dc.identifier.doi	10.1200/JCO.18.00420
dc.relation.issue	1
dc.relation.volume	37

Files in this item

Files	Size	Format	View
There are no files associated with this item.